Post-approval studies (Phase 4)Study completedNCT02694263
What this trial is testing
Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan
Who this might be right for
Diabetes Mellitus, Type 2
University of Leicester 25